Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Jan 15;30(2):126785.
doi: 10.1016/j.bmcl.2019.126785. Epub 2019 Nov 9.

In vivo comparison of N-11CH3 vs O-11CH3 radiolabeled microtubule targeted PET ligands

Affiliations

In vivo comparison of N-11CH3 vs O-11CH3 radiolabeled microtubule targeted PET ligands

J S Dileep Kumar et al. Bioorg Med Chem Lett. .

Abstract

Altered dynamics of microtubules (MT) are implicated in the pathophysiology of a number of brain diseases. Therefore, radiolabeled MT targeted ligands that can penetrate the blood brain barrier (BBB) may offer a direct and sensitive approach for diagnosis, and assessing the clinical potential of MT targeted therapeutics using PET imaging. We recently reported two BBB penetrating radioligands, [11C]MPC-6827 and [11C]HD-800 as specific PET ligands for imaging MTs in brain. The major metabolic pathway of the above molecules is anticipated to be via the initial labeling site, O-methyl, compared to the N-methyl group. Herein, we report the radiosynthesis of N-11CH3-MPC-6827 and N-11CH3-HD-800 and a comparison of their in vivo binding with the corresponding O-11CH3 analogues using microPET imaging and biodistribution methods. Both O-11CH3 and N-11CH3 labeled MT tracers exhibit high specific binding and brain. The N-11CH3 labeled PET ligands demonstrated similar in vivo binding characteristics compared with the corresponding O-11CH3 labeled tracers, [11C]MPC-6827 and [11C]HD-800 respectively.

Keywords: Brain; Microtubule; PET; Radiotracer; Tubulin.

PubMed Disclaimer

Conflict of interest statement

Declaration of Competing Interest

J John Mann receives royalties for commercial use of the C-SSRS from the Research Foundation of Mental Hygiene. All other authors delcare that no conflict of interest.

Figures

Fig. 1.
Fig. 1.
Chemical structures of MPC-6827 and HD-800.
Fig. 2.
Fig. 2.
Radiosynthesis of N-11CH3-MPC-6827 and N-11CH3-HD-800.
Fig. 3.
Fig. 3.
Representative 0–30 min summed sagittal and transaxial PET images of O-11CH3-MPC-6827 and N-11CH3-MPC-6827 in mice (A: control O-11CH3-MPC-6827; B: blocking of O-11CH3-MPC-6827 with HD-800; C: Control N-11CH3-MPC-6827; D: Blocking of N-11CH3-MPC-6827 with HD-800).
Fig. 4.
Fig. 4.
Representative 0–30 min summed sagittal and transaxial PET images of O-11CH3-HD-800 and N-11CH3-HD-800 in mice (A: control O-11CH3-HD-800; B: blocking of O-11CH3-HD-800 with MPC-6827; C: Control N-11CH3-HD-800; D: Blocking of N-11CH3-HD-800 with MPC-6827).
Fig. 5.
Fig. 5.
Baseline and blocking time activity curves of O-11CH3-MPC-6827 (A) and N-11CH3-MPC-6827 (B) in mice brain.
Fig. 6.
Fig. 6.
Baseline and blocking time activity curves of O-11CH3-HD-800 (A) and N-11CH3-HD-800 (B) in mice brain.
Fig. 7.
Fig. 7.
Biodistribution O-11CH3-MPC-6827 and N-11CH3-MPC-6827 in mice at 30 min (n = 3) with *p values ≤ 0.05 considered statistically significant.
Fig. 8.
Fig. 8.
Biodistribution O-11CH3-HD-800 and N-11CH3-HD-800 in mice at 30 min (n = 3), with *p values ≤ 0.05 considered statistically significant.

Similar articles

Cited by

References

    1. Dubey J, Ratnakaran N, Koushika SP. Neurodegeneration and microtubule dynamics: death by a thousand cuts. Front Cell Neurosci. 2015;9:343. - PMC - PubMed
    1. Janke C The tubulin code: molecular components, readout mechanisms, and functions. J Cell Biol. 2014;206:461–472. - PMC - PubMed
    1. Barlan K, Gelfand VI. Microtubule-based transport and the distribution, tethering, and organization of organelles. Cold Spring Harb Perspect Biol. 2017;9 a025817. - PMC - PubMed
    1. Nogales E Structural insights into microtubule function. Ann Rev Biochent. 2010;69:277–302. - PubMed
    1. Katsuno M, Sahashi K, Iguchi Y, Hashizume A. Preclinical progression of neurodegenerative diseases. Nagoya J Med Sci. 2018;80:289–298. - PMC - PubMed

Publication types

LinkOut - more resources